Prognosis in patients with cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Neoplastic Stem Cells Breast Tumor Cells, Cultured Lymph Nodes Prostate MCF-7 Cells HCT116 Cells Neoplastic Cells, Circulating HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases60

Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Stomach Neoplasms Prostatic Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Colonic Neoplasms Pancreatic Neoplasms Neoplasms Disease Progression Carcinoma, Squamous Cell Carcinoma Neoplasm Recurrence, Local Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Genetic Predisposition to Disease Urinary Bladder Neoplasms Adenocarcinoma Liver Neoplasms Esophageal Neoplasms Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Head and Neck Neoplasms Mouth Neoplasms Bone Neoplasms Skin Neoplasms Neovascularization, Pathologic Carcinoma, Small Cell Neoplasms, Glandular and Epithelial Neoplasms, Hormone-Dependent Melanoma Neoplasms, Second Primary Gastrointestinal Neoplasms Kidney Neoplasms Brain Neoplasms Thyroid Neoplasms Neoplasms, Radiation-Induced Precancerous Conditions Carcinoma, Hepatocellular Genital Neoplasms, Female Recurrence Adenocarcinoma, Mucinous Neoplasms, Multiple Primary Carcinoma, Pancreatic Ductal Lymphatic Metastasis Mammary Neoplasms, Experimental Neoplastic Cells, Circulating Pharyngeal Neoplasms Carcinoma, Lobular Testicular Neoplasms Carcinoma, Intraductal, Noninfiltrating Disease Models, Animal Microsatellite Instability Breast Neoplasms, Male Peritoneal Neoplasms Carcinoma in Situ Chromosome Aberrations

Chemicals and Drugs51

Tumor Markers, Biological Neoplasm Proteins Cancer Vaccines Antineoplastic Agents Receptors, Estrogen Receptor, erbB-2 RNA, Messenger DNA, Neoplasm Tumor Suppressor Protein p53 Receptors, Progesterone RNA, Small Interfering Prostate-Specific Antigen Antigens, Neoplasm Fluorouracil Cisplatin Tamoxifen Antineoplastic Agents, Hormonal MicroRNAs Receptor, Epidermal Growth Factor Antineoplastic Agents, Phytogenic Tumor Suppressor Proteins Antibodies, Monoclonal Paclitaxel RNA, Neoplasm Anticarcinogenic Agents Ki-67 Antigen Proto-Oncogene Proteins Deoxycytidine Antimetabolites, Antineoplastic DNA-Binding Proteins Nuclear Proteins Transcription Factors Taxoids Antibodies, Monoclonal, Humanized Receptors, Androgen Carcinoembryonic Antigen BRCA2 Protein Biological Markers Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors Cadherins Estrogens Cyclophosphamide BRCA1 Protein Androgens Estrogen Receptor alpha Vascular Endothelial Growth Factor A Proto-Oncogene Proteins c-bcl-2 Carcinogens beta Catenin Quinazolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Prognosis Early Detection of Cancer Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Neoplasm Staging Disease-Free Survival Kaplan-Meier Estimate Prospective Studies Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Multivariate Analysis Combined Modality Therapy Treatment Outcome Risk Assessment Risk Risk Factors Predictive Value of Tests Registries Immunohistochemistry Xenograft Model Antitumor Assays Chemotherapy, Adjuvant Blotting, Western Sensitivity and Specificity Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Tissue Array Analysis Odds Ratio Neoplasm Grading Transplantation, Heterologous Tumor Burden Polymerase Chain Reaction Immunoenzyme Techniques Clinical Trials as Topic Molecular Targeted Therapy Reproducibility of Results Questionnaires Mammography SEER Program Incidence Logistic Models Cohort Studies Biopsy Drug Screening Assays, Antitumor Radiotherapy Transfection Tomography, X-Ray Computed Palliative Care Models, Biological Confidence Intervals Flow Cytometry Gene Knockdown Techniques Radiotherapy, Adjuvant DNA Mutational Analysis Drug Administration Schedule Chi-Square Distribution Mastectomy In Situ Hybridization, Fluorescence Real-Time Polymerase Chain Reaction Lymph Node Excision Mammary Neoplasms, Experimental Proportional Hazards Models Gastrectomy Immunotherapy Genetic Testing Regression Analysis ROC Curve Disease Models, Animal Prostatectomy Positron-Emission Tomography

Psychiatry and Psychology1

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Mutation DNA Methylation Sensitivity and Specificity Odds Ratio Genotype Cell Proliferation Time Factors Cell Survival Cell Movement Down-Regulation Apoptosis Genes, BRCA1 Polymorphism, Genetic Cell Division Up-Regulation Cell Cycle Promoter Regions, Genetic Cell Growth Processes Genes, p53 Dose-Response Relationship, Drug Genes, Tumor Suppressor RNA Interference Genes, Neoplasm Gene Silencing Transfection Phenotype Gene Expression Signal Transduction Germ-Line Mutation Base Sequence Gene Amplification Chi-Square Distribution Postmenopause Epithelial-Mesenchymal Transition Phosphorylation Genes, BRCA2 Diet Alleles Loss of Heterozygosity Tumor Microenvironment Epigenesis, Genetic CpG Islands Genes, erbB-2 Genes, ras Microsatellite Instability Drug Synergism Chromosome Aberrations

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires SEER Program Incidence Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care35

Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Disease-Free Survival Kaplan-Meier Estimate Prospective Studies Multivariate Analysis Treatment Outcome Risk Assessment Risk Risk Factors Predictive Value of Tests Registries Age Factors National Cancer Institute (U.S.)Sensitivity and Specificity Odds Ratio Clinical Trials as Topic Reproducibility of Results Questionnaires SEER Program Incidence Logistic Models Cohort Studies Palliative Care Confidence Intervals American Cancer Society Chi-Square Distribution Sex Factors Proportional Hazards Models Age Distribution Genetic Testing Regression Analysis ROC Curve

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prognosis Early Detection of Cancer Breast Neoplasms Lung Neoplasms Survival Analysis Ovarian Neoplasms Survival Rate Stomach Neoplasms Prostatic Neoplasms Neoplasm Invasiveness Tumor Markers, Biological Neoplasm Metastasis Gene Expression Regulation, Neoplastic Follow-Up Studies Retrospective Studies Neoplasm Staging Colonic Neoplasms Pancreatic Neoplasms Neoplasms Neoplasm Proteins Disease Progression Mice, Nude Disease-Free Survival Carcinoma, Squamous Cell Kaplan-Meier Estimate Prospective Studies Carcinoma Cell Line, Tumor Antineoplastic Combined Chemotherapy Protocols Cancer Vaccines Neoplasm Recurrence, Local Antineoplastic Agents Gene Expression Profiling Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Reverse Transcriptase Polymerase Chain Reaction Uterine Cervical Neoplasms Multivariate Analysis Genetic Predisposition to Disease Receptors, Estrogen Combined Modality Therapy Drug Resistance, Neoplasm Receptor, erbB-2 Treatment Outcome Risk Assessment Urinary Bladder Neoplasms Risk Adenocarcinoma Mutation Risk Factors Predictive Value of Tests Registries RNA, Messenger Age Factors Immunohistochemistry Liver Neoplasms DNA, Neoplasm Esophageal Neoplasms Xenograft Model Antitumor Assays Rectal Neoplasms National Cancer Institute (U.S.)Tumor Suppressor Protein p53 Chemotherapy, Adjuvant Survivors Blotting, Western DNA Methylation United States Endometrial Neoplasms Cell Transformation, Neoplastic Sensitivity and Specificity Neoplasm Transplantation Receptors, Progesterone RNA, Small Interfering Oligonucleotide Array Sequence Analysis Tissue Array Analysis Odds Ratio Neoplasm Grading Prostate-Specific Antigen Antigens, Neoplasm Fluorouracil Cisplatin Medical Oncology Genotype Neoplastic Stem Cells Smoking Cell Proliferation Head and Neck Neoplasms Time Factors Transplantation, Heterologous Tumor Burden Mouth Neoplasms Tamoxifen Cell Survival Cell Movement Down-Regulation Polymerase Chain Reaction Bone Neoplasms Skin Neoplasms Immunoenzyme Techniques Apoptosis

No FAQ available that match "prognosis in patients with cancer"